surmount-2 tirzepatide type 2 diabetes weight loss results 2023 2024 cuts risk by 94% in SURMOUNT-1 trial SURMOUNT-2: Tirzepatide confers about 15%

Mounjaro 2.5mg Solution for Injection improves blood sugar control in adults with type 2 diabetes when used in conjunction with a balanced diet and regular exercise

Read our guide to weight loss shots and how they work

and was approved in May 2022

Here is the standard tirzepatide injection dosage chart: A few things to notice

Pancreatitis: Pancreas inflammation has been reported as a potential side effect although it is a rare side effect

At week 112, mean weight change from baseline was 22.4% with MTD (representing 100% maintenance prior to weight reduction), 17.0% with 5mg (~70% maintenance), and 10.1% with placebo